| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |